文献リスト

1) O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002; 51(RR-10): 1-29. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm

2) Langgartner J, Linde HJ, Lehn N, et al. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonization of central venous catheters. Intensive Care Med. 2004; 30: 1081-8

3) Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. American Society for Parenteral and Enteral Nutrition. J Parenter Enteral Nutr. 1993; 17: 1SA-52SA

4) Payne-James JJ, Khawaja HT. First choice for total parenteral nutrition: the peripheral route. J Parenter Enteral Nutr. 1993; 17: 468-78

5) Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. 1999. Infect Control Hosp Epidemiol. 1999; 20: 248-78

6) El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg. 1996; 61: 1030-6

7) El Oakley R, Paul E, Wong PS, et al. Mediastinitis in patients undergoing cardiopulmonary bypass: risk analysis and midterm results. J Cardiovasc Surg. 1997; 38: 595-600

8) Trick WE, Scheckler WE, Tokars JI, et al. Modi­fiable risk factors associated with deep sternal site infection after coronary artery bypass graft­ing. J Thorac Cardiovasc Surg. 2000; 119: 108-14

9) Gardlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery - microbiology and pathogenesis. Eur J Cardiothorac Surg. 2002; 21: 825-30

10) Nishida H, Grooters RK, Soltanzadeh H, et al. Discriminate use of electrocautery on the median sternotomy incision. A 0. 16% wound infection rate. J Thorac Cardiovasc Surg. 1991; 101: 488-94

11) Baskett RJ, MacDougall CE, Ross DB. Is media­stinitis a preventable complication？ A 10-year review. Ann Thorac Surg. 1999; 67: 462-5

12) Engelman R, Shahian D, Shemin R, et al. Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007; 83: 1569-76

13) Mekontso-Dessap A, Honore S, Kirsch M, et al. Blood neutrophil bactericidal activity against methicillin-resistant and methicillin-sensitive Staphylococcus aureus during cardiac surgery. Shock. 2005; 24: 109-13

14) Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylo­coccus aureus infections. N Engl J Med. 2002; 346: 1871-7

15) Mishriki SF, Law DJ, Jeffery PJ. Factors affecting the incidence of postoperative wound infection. J Hosp Infect. 1990; 16: 223-30

16) 厚生労働省通知｢医療施設における院内感染の防止について｣ 平成17年02月01日 医政指発第201004号 http://www.mhlw.go.jp/topics/2005/02/tp0202-1.html

17) Ko W, Lazenby WD, Zelano JA, et al. Effects of shaving methods and intraoperative irrigation on suppurative mediastinitis after bypass operations. Ann Thorac Surg. 1992; 53: 301-5

18) Parienti JJ, Thibon P, Heller R, et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates. A randomized equivalence study. JAMA. 2002; 288: 722-7

19) Pereira LJ, Lee GM, Wade KJ. An evaluation of five protocols for surgical handwashing in rela­tion to skin condition and microbial counts. J Hosp Infect. 1997; 36: 49-65

20) Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep. 2002; 51(RR-16): 1-45. http://www.cdc.gov/handhygiene/

21) 針原 康, 小西敏郎, 奈良智之, 他. エビデンスに基づいた合理的な手術室感染対策-当院の手術室の特徴も含めて-. 日本外科感染症学会雑誌. 2006; 3: 255-60

22) Kikuchi-Numagami K, Saishu T, Fukaya M, et al. Irritancy of scrubbing up for surgery with or without a brush. Acta Derm Venereol. 1999; 79: 230-2

23) 日本手術医学会. 手術医療の実践ガイドライン. http://jaom.umin.ne.jp/new1001013.html

24) Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of anti­biotics and the risk of surgical-wound infection. N Engl J Med. 1992; 326: 281-6

25) ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation. 2004; 110: e340-437

26) Craig WA. Interrelationship between pharmaco­kinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalo­sporins. Diagn Microbiol Infect Dis. 1995; 22: 89-96

27) 宮原 健, 松浦昭雄, 吉田勝彦, 他. 心臓血管外科における手術部位感染予防-科学的根拠に基づいた対策の実践と予防的抗菌薬の適正使用. 日本集中治療医会誌. 2007; 14: 187-95

28) Edwards FH, Engelman RM, Houck P, et al. Society of Thoracic Surgeons. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic prophylaxis in cardiac surgery, Part I: Duration. Ann Thorac Surg. 2006; 81: 397-404

29) Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardio­vascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000; 101: 2916-21

30) 藤本卓司. 手術部位感染症 MRSAによる手術部位感染症の予防にグリコペプチド系薬およびムピロシンの投与は有効か. EBMジャーナル. 2002; 3: 48-53

31) McDonald M, Grabsch E, Marshall C, et al. Single versus multiple-dose antimicrobial prophy­laxis for major surgery: a systematic review. Aust NZ J Surg. 1998; 68: 388-96

32) Kriaras I, Michalopoulos A, Michalis A, et al. Antibiotic prophylaxis in cardiac surgery. J Cardiovasc Surg(Torino). 1997; 38: 605-10

33) Nooyen SM, Overbeek BP, Brutel de la Riviere A, et al. Prospective randomized comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting. Eur J Clin Microbiol Infect Dis. 1994; 13: 1033-7

34) Scher KS. Studies on the duration of antibiotic administration for surgical prophylaxis. Am Surg. 1997; 63: 59-62

35) Bratzler DW, Houck PM. Antimicrobial prophy­laxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004; 38: 1706-15

36) Kreisel D, Savel TG, Silver AL, et al. Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg. 1995; 130: 989-93

37) Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis. 1994; 18: 422-7

38) Korniewicz DM, Laughon BE, Butz A, et al. Integrity of vinyl and latex procedures gloves. Nurs Res. 1989; 38: 144-6

39) Bennett B, Duff P. The effect of double gloving on frequency of glove perforations. Obstet Gynecol. 1991; 78: 1019-22

40) Tokars JI, Culver DH, Mendelson MH, et al. Skin and mucous membrane contacts with blood during surgical procedures: risk and prevention. Infect Control Hosp Epidemiol. 1995; 16: 703-11

41) Berridge DC, Starky G, Jones NA, et al. A randomized controlled trial of double-versus single-gloving in vascular surgery. J R Coll Surg Edinb. 1998; 43: 9-10

42) Ceydeli A, Rucinski J, Wise L. Finding the best abdominal closure: an evidence-based review of the literature. Curr Surg. 2005; 62: 220-5

43) Cervantes-Sanchez CR, Gutierrez-Vega R, Vazquez-Carpizo JA, et al. Syringe pressure irrigation of subdermic tissue after appendectomy to decrease the incidence of postoperative wound infection. World J Surg. 2000; 24: 38-42

44) 佐貫潤一, 古嶋 薫, 大塚裕一, 他. 大腸手術における術後感染予防対策. 日本外科感染症研究. 2002; 14: 175-9

45) Leaper D. Antiseptics in wound healing. Nurs Times. 1996; 92: 63-8

46) Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma. 1991; 31: 775-84

47) Winter GD. Fornation of the scab and the epithelization of the superficial wounds in the skin of the young domestic pig. Nature. 1962; 193: 293-4

48) 嶋 裕一, 小矢崎直博, 大戸 司. 術後創傷(縫合創)に対する薄型ハイドロコロイドドレッシング(KYD)の臨床効果. 臨床と研究. 1998; 75: 669-79

49) 富士森良輔, 野瀬京子, 楠瀬 恵, 他. 開放創に対する薄型ハイドロコロイドドレッシング(KYD)の使用経験. 皮紀. 1998; 93: 99-110

50) 田澤賢次, 笠木徳三, 山本克弥, 他. 各種皮膚保護材のpH値と貼用時における皮膚表面pH値とその変化. 日ストーマリハ会誌. 1989; 5: 39-45

51) Hutchinson JJ, McGuckin M. Occlusive dress­ings: A microbiologic and clinical review. Am J Infect Control. 1990; 18: 257-68

52) Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill pa­tients. N Engl J Med. 2001; 345: 1359-67

53) Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008; 300: 933-44

54) NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360: 1283-97

55) Krinsley JS. Effect of an intensive glucose management protocol on the mortality of criti­cally ill adult patients. Mayo Clin Proc. 2004; 79: 992-1000

56) Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001; 22: 607-12

57) Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004; 10 Suppl 2: 21-33

58) Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical pro­cedures. Ann Thorac Surg. 1999; 67: 352-60

59) Greif R, Aksa O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med. 2000; 342: 161-7

60) Pryor KO, Fahey III TJ, Lien CA, et al. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population. A randomized controlled trial. JAMA. 2004; 291: 79-87

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp